Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06619678
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-27
Brief Title:
A Study of MK-8507 and Islatravir MK-8591 in Healthy Adult Participants MK-8507-016
Sponsor:
None
Organization:
None
Study Overview
Official Title:
An Open-Label Study to Assess the Two-Way Interaction Between Multiple Weekly Doses of MK-8507 and Single Doses of Islatravir MK-8591 in Healthy Adult Participants
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main goals of this study are to learn what happens to Islatravir or MK-8507 in a persons body over time Researchers will compare Islatravir given alone to Islatravir given with MK-8507 Researchers will also compare MK-8507 given alone to MK-8507 given with Islatravir
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None